Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

NCT04022109 is registered in ClinicalTrials.gov with University of Latvia as lead sponsor.

NCT NCT04022109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04022109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
Lead sponsor
University of Latvia
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2019
Completion date
December 31, 2026
Enrollment
5,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

atrophic gastritis, gastric cancer, gastric dysplasia, h.pylori infection